Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
50 Cards in this Set
- Front
- Back
Describe carcinogenesis
|
Cancer is a multistep process involving gene mutations, telomerase activation, angiogenesis, invasion, and metastasis
|
|
Describe the types of gene mutations involved in carcinogenesis
|
1. Point mutations are the most common type of mutation
2. Balanced translocations 3. Other mutations -Deletion, gene amplification (multiple copies of a gene), overexpression (increase in baseline gene activity) |
|
Describe proto-oncogenes
|
1. Involves in normal growth and repair
2. Functions of proto-oncogene protein products -Growth factors, growth factor receptors, signal transducer, nuclear transcribers 3. Mutations cause sustained activity of the genes |
|
Describe tumor suppressor genes (anti-oncogenes)
|
1. Protect against unregulated cell growth
2. Control G1 to S phase of the cell cycle and nuclear transcription 3. Mutations cause unregulated cell proliferation |
|
Describe antiapoptosis genes
|
-BCL2 family of genes
1. Protein products prevent cytochrome C from leaving mitochondria -Cytochrome c in the cytosol activates caspases initiating apoptosis 2. Mutation causes increased gene activity (eg, overexpression), which prevents apoptosis; eg B-cell follicular lymphoma a. BCL2 gene family (chromosome 18) produces gene products that prevent mitochondrial leakage of cytochrome c (signal for apoptosis) b. Translocation t(14;18) causes overexpression of the BCL2 protein product. -Prevents apoptosis of B lymphocytes causing B-cell follicular lymphoma |
|
Describe the apoptosis genes
|
1. Regulate programmed cell gene
2. Example: BAX apoptosis gene a. Activated by a TP53 suppressor gene product if DNA damage is excessive b. BAX protein product inactivates the BCL2 antiapoptosis gene c. Mutation inactivating TP53 suppressor gene renders the BAX gene inoperative, which prevents apoptosis |
|
Describe the causes of cancer
|
1. External factors
-Tobacco, alcohol, chemicals, radiation, pathogens 2. Internal factors -Hormones, immune conditions, inherited mutations |
|
Describe the function, mutation, and cancer associated with the proto-oncogene ABL
|
Function: Nonreceptor tyrosine kinase activity
Mutation: Translocation t(9;22) Cancer: Chronic myelogenous leukemia (chromosome 22 is Philadelphia chromosome) |
|
Describe the function, mutation, and cancer associated with the proto-oncogene HER (ERBB2)
|
Function: Receptor synthesis
Mutation: Amplification Cancer: Breast carcinoma (marker of aggressiveness) |
|
Describe the function, mutation, and cancer associated with the proto-oncogene MYC
|
Function: Nuclear transcription
Mutation: Translocation t(8;14) Cancer: Burkitt’s Lymphoma |
|
Describe the function, mutation, and cancer associated with the proto-oncogene N-MYC
|
Function: Nuclear transcription
Mutation: Amplification Cancer: Neuroblastoma |
|
Describe the function, mutation, and cancer associated with the proto-oncogene RAS
|
Function: Guanosine triphosphate signal transduction
Mutation: Point mutation Cancer: Leukemia; lung, colon, pancreatic carcinomas |
|
Describe the function, mutation, and cancer associated with the proto-oncogene RET
|
Function: Receptor synthesis
Mutation: Point mutation Cancer: Multiple endocrine neoplasia IIa/IIb syndromes |
|
Describe the function, mutation, and cancer associated with the proto-oncogene SIS
|
Function: Growth factor synthesis
Mutation: Overexpression Cancer: Osteogenic sarcoma, astrocytoma |
|
Describe the function and associated cancers associated with the tumor suppressor gene APC
|
Function: Prevents nuclear transcription (degrade catenin, an activator of nuclear transcription)
Associated cancers: Familial polyposis (colorectal carcinoma) |
|
Describe the function and associated cancers associated with the tumor suppressor gene BRCA1/BRCA2
|
Function: Regulates DNA repair
Associated cancers: Breast, ovary, prostate carcinomas |
|
Describe the function and associated cancers associated with the tumor suppressor gene RB (retinoblastoma)
|
Function: inhibits G1 to S phase
Associated cancers: Retinoblastoma, osteogenic sarcoma, breast carcinoma |
|
Describe the function and associated cancers associated with the tumor suppressor gene TGF-beta
|
Function: Inhibits G1 to S phase
Associated cancers: Pancreatic and colorectal carcinomas |
|
Describe the function and associated cancers associated with the tumor suppressor gene TP53
|
Function: (1)Inhibits G1 to S phase, (2) Repairs DNA, activates BAX gene (initiates apoptosis)
Associated cancers: (1) Lung, colon, breast carcinomas (2) Li-Fraumeni syndrome: breast carcinoma, brain tumors, leukemia, sarcomas |
|
Describe the function and associated cancers associated with the tumor suppressor gene VHL (von Hippel-Lindau)
|
Function: Regulates nuclear transcription
Associated cancers: Von Hippel-Lindau syndrome: cerebellar hemangioblastoma, retinal angioma, renal cell carcinoma (bilateral), pheochromocytoma (bilateral) |
|
Describe the function and associated cancers associated with the tumor suppressor gene WT1
|
Function: Regulates nuclear transcription
Associated cancers: Wilm’s tumor |
|
Describe DNA repair genes
|
1. Examples of DNA repair
a. Mismatch repair genes produce proteins that correct errors in nucleotide pairing b. Nucleotide excision repair pathway excises pyrimidine dimmers in UV light-damaged skin 2. Effect of mutations involving DNA repair genes -Allows cells with nonlethal damage to proliferate, which increases the risk for cancer |
|
What is the most common group of carcinogens in the US?
|
Polycyclic hydrocarbons in tobacco smoke
|
|
Describe the mechanisms for chemical carcinogens
|
1. Direct-acting carcinogens
-Contain electro-deficient atoms that react with electron-rich atoms in DNA (eg alkylating agents) 2. Indirect-acting carcinogens -Activated by the liver cytochrome P450 system (eg, polycyclic hydrocarbon) |
|
Describe the sequence of chemical carcinogenesis
|
1. Initiation
-Irreversible mutation 2. Promotion -Promoters (eg estrogen) stimulate mutated cells to enter the cell cycle 3. Progression a. Development of tumor heterogeneity b. Examples- production of cells that invade or metastasize |
|
Describe the associated cancers with the carcinogen aflatoxin (from Aspergillus)
|
Hepatocellular carcinoma in association with hepatitis B virus
|
|
Describe the associated cancers with the carcinogen alcohol
|
Squamous cell carcinoma of oropharynx and upper/middle esophagus; pancreatic and hepatocellular carcinomas
|
|
Describe the associated cancers with the carcinogen alkylating agents
|
Malignant lymphoma
|
|
Describe the associated cancers with the carcinogen arsenic
|
Squamous cell carcinoma of skin, lung cancer, liver angiosarcoma
|
|
Describe the associated cancers with the carcinogen asbestos
|
Bronchogenic carcinoma, pleural mesothelioma
|
|
Describe the associated cancers with the carcinogen benzene
|
Acute leukemia
|
|
Describe the associated cancers with the carcinogen beryllium
|
Bronchogenic carcinoma
|
|
Describe the associated cancers with the carcinogen chromium
|
Bronchogenic carcinoma
|
|
Describe the associated cancers with the carcinogen cyclophosphamide
|
Transitional cell carcinoma of urinary bladder
|
|
Describe the associated cancers with the carcinogen diethylstilbestrol
|
Clear cell carcinoma of vagina/cervix
|
|
Describe the associated cancers with the carcinogen beta-naphthylamine (aniline dyes)
|
Transitional cell carcinoma of urinary bladder
|
|
Describe the associated cancers with the carcinogen nickel
|
Bronchogenic carcinoma
|
|
Describe the associated cancers with the carcinogen oral contraceptives
|
Breast, cervical carcinomas
|
|
Describe the associated cancers with the carcinogen polycyclic hydrocarbons
|
1. Squamous cell carcinoma: oral cavity, midesophagus, larynx, lung
2. Adenocarcinoma: Distal esophagus, pancreas 3. Transitional cell carcinoma: Urinary bladder, renal pelvis |
|
Describe the associated cancers with the carcinogen polyvinyl chloride
|
Liver angiosarcoma
|
|
Describe the associated cancers with the carcinogen silica
|
Bronchogenic carcinoma
|
|
Describe the mechanism and associated cancer from the RNA virus HCV
|
Mechanism: Produces postnecrotic cirrhosis
Associated cancer; Hepatocellular carcinoma |
|
Describe the mechanism and associated cancer from the RNA virus HTLV-1
|
Mechanism: Activates TAX gene, stimulates polyclonal T-cell proliferation, inhibits TP53 suppressor gene
Associated Cancer: T-cell leukemia and lymphoma |
|
Describe the mechanism and associated cancer from the DNA virus EBV
|
Mechanism: Promotes polyclonal B-cell proliferation, which increases risk for t(8;14) translocation
Associated cancer: Burkitt’s lymphoma, CNS lymphoma in AIDS, mixed cellularity Hodgkin’s lymphoma, nasopharyngeal carcinoma |
|
Describe the mechanism and associated cancer from the DNA virus HBV
|
Mechanism: Activates proto-oncogenes, inactivates TP53 suppressor gene
Associated cacner: Hepatocellular |
|
Describe the mechanism and associated cancer from the DNA virus HHV-8
|
Mechanism: Acts via cytokines released from HIV and HSV
Associated cancers: Kaposi’s sarcoma in AIDS |
|
Describe the mechanism and associated cancer from the DNA virus HPV types 16 and 18
|
Mechanism
Type 16 (~50% of cancers): E6 gene product inhibits TP53 suppressor gene Type 18 (~10% of cancers): E7 gene product inhibits RB suppressor gene Associated Cancer: Squamous cell carcinoma of vulva, vagina, cervix, anus (associated with anal intercourse), larynx, oropharynx |
|
Describe microbes associated with cancer
|
1. Viruses
2. Bacteria -Examples: stomach cancer and low-grade malignant lymphoma due to H. pylori 3. Parasites a. Schistosoma hematobium -Squamous cell carcinoma b. Clonorchis sinesis and Opisthorchis viverrini |
|
Describe ionizing radiation-induced cancers
|
1. Mechanism
-Hydroxyl free radical injury to DNA 2. Examples a. Acute myelogenous or chronic myelogenous leukemia -Increased risk of leukemia in radiologists and individuals exposed to radiation in nuclear reactors b. Papillary thyroid carcinoma c. Lung, breast, and bone cancers d. Liver angiosarcoma -Due to radioactive thorium dioxide used to visualize the arterial tree |
|
Describe UV light-induced cancers
|
1. Mechanism
-Formation of pyrimidine dimers, which distort DNA 2. Basal cell carcinoma, squamous cell carcinoma, malignant melanoma |